About Us
Leadership Team
Our founders are globally acknowledged scientists and drug development leaders whose vision is to make a difference in AML patient care.

Florent Gros
Chief Executive Officer and Founder
Read more

Stephan Oehen
Chief Operating Officer
and Founder
Read more

Philippe Lievre
Chief Business Officer
and Founder
Read more

Brice Suire
Chief Financial Officer and Founder
Read more

Elisabeth Kueenburg
Chief Medical Officer
Read more
Functions Area Heads

Malika Souquières
Head Clinical Sciences & Operations
Read more

Karen Von Graevenitz
Head Regulatory Affairs
Read more

Simone Dertschnig
Head Research
Read more

Frédéric David
Head Technical Development
Read more
Supervisory Board
Our supervisory board is composed of venture capital leaders from leading international venture funds, also joined by Dr. Dhaval Patel, leader in S1Pr drug developments (Gilenya).

Manus Rogan
Chair
Read more

Dhaval Patel
Director
Read more

Marten Steen
Director
Read more

Henry Skinner
Director
Read more

Lionel Carnot
Director
Read more
Advisory Board

Christoph Bucher
Head of Clinical Advisory Board and Founder
Read more

Simone Seiter
Head of Commercial and Scientific Advisory Board and Founder
Read more